1A36.1) - Extraintestinal Infections by Entamoeba: Complete Coding Guide

1. Introduction

Extraintestinal infections caused by Entamoeba represent a serious and potentially fatal manifestation of amebiasis, occurring when the protozoan Entamoeba histolytica migrates beyond the gastrointestinal tract to affect other organs and systems. This condition is fundamentally distinguished from the intestinal form of the disease, requiring specific coding and a differentiated therapeutic approach.

The most common extraintestinal form is amebic liver abscess, responsible for the majority of cases, although the parasite can also invade the lungs, brain, skin, and other organs. The clinical importance of these infections lies in their high morbidity and mortality when not treated appropriately, in addition to the need for specialized diagnostic and therapeutic interventions that go beyond the management of simple amebic dysentery.

From an epidemiological perspective, extraintestinal infections represent a complication that occurs in a minority of patients infected with E. histolytica, but constitute medical emergencies that demand early recognition. The prevalence varies significantly among regions with different sanitary conditions, being more frequent in areas with inadequate basic sanitation and limited access to drinking water.

Precise coding using code 1A36.1 is critical for various purposes: it enables appropriate epidemiological tracking of these serious complications, facilitates allocation of appropriate hospital resources, guides specific treatment protocols, and enables comparative studies on clinical outcomes. The clear distinction between intestinal and extraintestinal forms directly impacts decisions regarding hospitalization, duration of treatment, and the need for invasive procedures.

2. Correct ICD-11 Code

Code: 1A36.1

Description: Extraintestinal infections by Entamoeba

Parent category: 1A36 - Amebiasis

This specific code was established in ICD-11 to capture all manifestations of Entamoeba histolytica infection that occur outside the intestinal tract. The classification recognizes that these clinical presentations have diagnostic, therapeutic, and prognostic characteristics substantially different from intestinal amebiasis, justifying distinct coding.

Code 1A36.1 encompasses a spectrum of clinical manifestations, including amebic liver abscess (the most prevalent form), pulmonary abscess, cerebral abscess, cutaneous amebiasis, and other less common localizations. The unification of these diverse presentations under a single code reflects the understanding that all share the same etiologic agent and fundamental pathophysiologic mechanism: hematogenous dissemination of the protozoan from a primary intestinal focus, which may or may not be clinically evident at the time of diagnosis.

The hierarchical structure of ICD-11 positions this code within the broader category of amebiasis (1A36), which in turn is inserted in the chapter of infectious or parasitic diseases. This organization facilitates searches and epidemiological analyses both specific and aggregated.

3. When to Use This Code

The code 1A36.1 should be used in specific clinical scenarios where there is confirmation or strong suspicion of extraintestinal dissemination of Entamoeba histolytica:

Scenario 1: Confirmed Amebic Liver Abscess Patient presenting with fever, right hypochondrial pain and painful hepatomegaly, with imaging studies (ultrasound or computed tomography) demonstrating cystic lesion in the liver. Serology for E. histolytica is positive, confirming amebic etiology. This is the most common scenario for application of code 1A36.1, representing the most prevalent extraintestinal form. Diagnosis can be established even in the absence of concomitant intestinal symptoms or prior history of dysentery, as the intestinal focus may be asymptomatic.

Scenario 2: Amebic Pulmonary Abscess Patient with productive cough, chest pain and dyspnea, frequently associated with pleural effusion. Chest radiography or computed tomography reveals cavitary pulmonary lesion, usually in the right lower lobe due to direct extension from hepatic abscess. Confirmation can be obtained by positive serology and/or identification of the parasite in aspiration material. This scenario, although less frequent than hepatic involvement, represents a serious complication requiring code 1A36.1.

Scenario 3: Amebic Brain Abscess Neurological presentation with severe headache, altered level of consciousness, focal neurological deficits or seizures. Neuroimaging demonstrates expansile brain lesion, and etiological investigation with serology and/or cerebrospinal fluid analysis suggests or confirms amebic etiology. This is a rare but extremely serious manifestation with high mortality, requiring precise coding with 1A36.1 to alert to the severity of the case.

Scenario 4: Cutaneous Amebiasis Ulcerated skin lesions, typically in the perianal, genital region or at surgical wound sites, with identification of E. histolytica trophozoites on biopsy or lesion scraping. Although uncommon, this manifestation represents direct parasite dissemination and should be coded as 1A36.1, especially when there is evidence of deep tissue invasion beyond the mucosal surface.

Scenario 5: Disseminated Amebiasis with Multiple Organ Involvement Immunocompromised or severely debilitated patient presenting with simultaneous involvement of multiple organs (liver, lung, spleen), confirmed by imaging studies and serology. This scenario represents the most severe form of extraintestinal disease and absolutely requires code 1A36.1, frequently necessitating additional codes to specify complications.

Scenario 6: Amebic Pericarditis Rare manifestation resulting from direct extension of hepatic abscess from the left lobe to the pericardium. Patient presents with chest pain, dyspnea and signs of cardiac tamponade. Echocardiogram reveals pericardial effusion, and investigation confirms amebic etiology. This specific scenario, although rare, should be coded as 1A36.1 due to extraintestinal location.

4. When NOT to Use This Code

It is essential to recognize situations where code 1A36.1 is not appropriate, avoiding coding errors that may compromise medical records and epidemiological statistics:

Intestinal Infection by Entamoeba (1A36.0) When the patient presents exclusively with gastrointestinal manifestations of amebiasis - dysentery, amebic colitis, bloody diarrhea - without evidence of extraintestinal dissemination, the correct code is 1A36.0. The presence of abdominal pain, bowel movements with blood and mucus, and tenesmus, even when severe, does not justify the use of 1A36.1 if the involvement remains confined to the intestinal tract.

Asymptomatic Carrier of E. histolytica Individuals with positive stool parasitological examination for E. histolytica or E. dispar, but without any clinical manifestations, should not receive code 1A36.1. Even the presence of the parasite without tissue invasion requires different coding or may not require coding of active disease.

Hepatic Abscesses of Other Etiologies Pyogenic bacterial, fungal, or other parasitic hepatic abscesses should not be coded as 1A36.1, even when initial differentiation is challenging. Etiological confirmation through negative serology for E. histolytica, positive cultures for bacteria, or other specific findings indicates the need for alternative codes appropriate to the identified etiology.

Infections by Other Species of Entamoeba Non-pathogenic species such as Entamoeba dispar, E. coli, E. hartmanni do not cause invasive disease and should not be coded as 1A36.1. Laboratory differentiation between E. histolytica (pathogenic) and E. dispar (non-pathogenic) is essential for appropriate coding.

Post-Treatment Complications Sequelae or complications occurring after successful treatment of extraintestinal amebiasis, such as stenosis, scarring, or residual organ dysfunction, should not receive code 1A36.1 if there is no active infection present. These situations require codes for specific sequelae or complications.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

The first essential step is to confirm that the diagnosis of extraintestinal infection by Entamoeba is adequately established. This confirmation requires:

Clinical Evidence: Identify manifestations compatible with extraintestinal involvement - fever, pain localized to the affected organ, signs of inflammatory or infectious process in non-intestinal location. The epidemiological history of exposure (travel to endemic areas, inadequate sanitary conditions) strengthens the suspicion.

Laboratory Evidence: Positive serology for E. histolytica is the most sensitive and specific diagnostic method for extraintestinal forms, with positivity in more than 90% of cases of hepatic abscess. Antigen detection tests in feces or tissues, molecular methods (PCR), and occasionally direct microscopic identification of trophozoites in aspirated material can confirm the diagnosis.

Radiological Evidence: Imaging studies are fundamental. Ultrasonography, computed tomography, or magnetic resonance imaging demonstrating cystic lesions or abscesses in extraintestinal organs (liver, lung, brain) are essential to establish the location and extent of infection.

Step 2: Verify Specifiers

After confirming the diagnosis, assess specific characteristics that may require additional documentation:

Anatomical Location: Clearly document which organ is affected (hepatic, pulmonary, cerebral, cutaneous), as although all use the same code 1A36.1, specification in clinical documentation is crucial for appropriate management.

Severity: Assess whether there are complications such as abscess rupture, extension to adjacent structures, secondary sepsis, or involvement of multiple organs. This information may require additional codes for complications.

Response to Treatment: Although it does not change the primary code, documenting whether the case is of first presentation, recurrence, or treatment failure is important for complete record-keeping.

Step 3: Differentiate from Other Codes

1A36.0 vs 1A36.1: The fundamental differentiation lies in the location of infection. If involvement is exclusively intestinal (colon), use 1A36.0. If there is dissemination to the liver, lung, or any other extraintestinal organ, use 1A36.1. Patients may have both forms simultaneously, a situation in which both codes may be appropriate, but the extraintestinal code generally takes precedence due to greater severity.

Differentiation from Abscesses of Other Etiologies: Serology for E. histolytica is the key differentiator. Bacterial pyogenic abscesses typically present with negative serology, positive bacterial cultures, and distinct radiological characteristics (multiple small lesions versus single large lesion typical of amebiasis).

Step 4: Required Documentation

For appropriate coding with 1A36.1, the medical documentation must include:

Mandatory Checklist:

Clear description of clinical presentation and extraintestinal location
Results of imaging studies with description of lesions
Results of serology for E. histolytica or other confirmatory tests
Exclusion of relevant differential diagnoses
Specific therapeutic plan for extraintestinal form
Assessment of associated complications

Appropriate Record: The medical note should explicitly state that it is "extraintestinal infection by Entamoeba" or "hepatic/pulmonary/cerebral amebic abscess," avoiding vague terms such as "amebiasis" without specification, which may generate ambiguity in coding.

6. Complete Practical Example

Clinical Case

A 42-year-old male patient presents to the emergency department with chief complaint of high fever (39°C) for 10 days, intense pain in the right hypochondrium for 5 days, and weight loss of 4 kg in the past month. He reports profuse night sweats and generalized malaise. He denies current diarrhea but mentions an episode of loose stools with mucus approximately 2 months ago, which resolved spontaneously without treatment.

On physical examination, the patient appears in fair general condition, febrile, tachycardic (HR: 110 bpm). Abdomen with painful hepatomegaly on palpation, liver palpable 4 cm below the right costal margin, with pain on sudden decompression in the right hypochondrium. No jaundice or ascites. Lung auscultation without abnormalities. No signs of diffuse peritoneal irritation.

Evaluation Performed:

Initial laboratory tests reveal leukocytosis (15,000/mm³) with neutrophilia, mild anemia (hemoglobin 11 g/dL), elevated erythrocyte sedimentation rate (80 mm/h), and increased C-reactive protein (120 mg/L). Liver function shows mild elevation of transaminases (AST 85 U/L, ALT 95 U/L) and moderately elevated alkaline phosphatase (250 U/L). Bilirubin levels normal.

Abdominal ultrasound demonstrates a single cystic lesion in the right lobe of the liver, measuring 8 cm in diameter, with heterogeneous content and without internal septations, located in segment VI. No bile duct dilatation or other hepatic lesions.

Abdominal computed tomography confirms a single hepatic abscess in the right lobe, with characteristics suggestive of amebic etiology (rounded lesion, hypodense, without significant peripheral enhancement).

Serology for Entamoeba histolytica (ELISA test for IgG antibody detection) returns strongly positive. Blood cultures collected are negative. Parasitological stool examination demonstrates no cysts or trophozoites.

Diagnostic Reasoning:

The combination of prolonged fever, right hypochondrial pain, painful hepatomegaly, and single hepatic cystic lesion in a patient with compatible epidemiological history (previous episode of diarrhea) strongly suggests amebic hepatic abscess. The positive serology for E. histolytica confirms the diagnosis. The absence of current diarrhea is common, as the extraintestinal manifestation may occur weeks or months after the initial intestinal infection, often asymptomatic. The negativity of the parasitological stool examination does not exclude the diagnosis, as the sensitivity of this examination is limited and the intestinal phase may have been transitory.

Coding Justification:

This case clearly represents an extraintestinal infection by Entamoeba, with hepatic involvement confirmed by imaging and serology. There is no evidence of active intestinal disease at the time of presentation. The abscess is located outside the gastrointestinal tract, characterizing hematogenous dissemination of the parasite.

Step-by-Step Coding

Criteria Analysis:

Extraintestinal clinical manifestation: ✓ (hepatic abscess)
Imaging confirmation: ✓ (ultrasound and computed tomography)
Laboratory confirmation: ✓ (positive serology)
Exclusion of other etiologies: ✓ (negative blood cultures)

Code Selected: 1A36.1 - Extraintestinal infections due to Entamoeba

Complete Justification:

Code 1A36.1 is appropriate because:

The infection is located in the liver, an extraintestinal organ
There is etiological confirmation by serology specific for E. histolytica
There is no evidence of concomitant active intestinal disease
The clinical and radiological characteristics are typical of amebic hepatic abscess

Applicable Complementary Codes:

Although the primary code is 1A36.1, additional codes may be considered for:

Fever (MG26): if the objective is to document this symptom separately
Hepatic abscess without further specification: generally not necessary as 1A36.1 already specifies the etiology
Procedure codes: if aspiration or drainage of the abscess is performed

Documented Therapeutic Plan:

Intravenous metronidazole initiated at amebicidal dose, followed by a luminal agent (paromomycin) after the acute phase. Patient evolved with significant clinical improvement after 72 hours of treatment, with defervescence and pain reduction. Ultrasound follow-up scheduled for 4-6 weeks to evaluate abscess resolution.

7. Related Codes and Differentiation

Within the Same Category

1A36.0: Intestinal infection by Entamoeba

This is the most critical differentiation for coders. Code 1A36.0 should be used when the infection remains confined to the intestinal tract, manifesting as amebic colitis, dysentery, or amebic diarrhea. Distinctive characteristics include:

When to use 1A36.0:

Diarrhea with blood and mucus (amebic dysentery)
Colitis confirmed by colonoscopy with typical ulcers
Exclusively gastrointestinal symptoms
Positive parasitological stool examination with intestinal manifestations
Absence of extraintestinal involvement on imaging studies

When to use 1A36.1:

Presence of abscess or lesion in extraintestinal organ
Documented hematogenous dissemination
Systemic symptoms with involvement of liver, lung, brain, or other organs
May or may not have concomitant intestinal symptoms

Main Difference: The anatomical location of the infection is the determining factor. Intestinal = 1A36.0; Extraintestinal = 1A36.1. In rare cases where both forms coexist, both codes may be applied, but 1A36.1 generally takes precedence due to greater severity.

Differential Diagnoses

Pyogenic Liver Abscesses (Code varies according to bacterial etiology): Differentiation based on: positive blood cultures for bacteria, multiple small lesions (versus single large lesion in amebiasis), negative serology for E. histolytica, patients frequently with comorbidities such as diabetes or biliary disease.

Hepatic Echinococcosis (1F72): Cystic lesions with distinct radiological characteristics (hydatid cysts with membranes, daughter vesicles), specific serology for Echinococcus, different epidemiological history (contact with dogs in endemic areas).

Hepatic Neoplasms: Differentiation by radiological characteristics, tumor markers, absence of fever and systemic inflammatory response, negative serology for amebiasis.

8. Differences with ICD-10

In the ICD-10 classification, extraintestinal infections by Entamoeba were coded under A06.4 - Amebic liver abscess and A06.5 - Amebic lung abscess, with specific subdivisions for each anatomical location. Other extraintestinal locations were classified under A06.8 - Amebic infection of other sites.

Main Changes in ICD-11:

ICD-11 consolidated all extraintestinal manifestations under the single code 1A36.1, simplifying coding and eliminating the need to memorize multiple codes for different locations. This change reflects a unified pathophysiological understanding: all represent hematogenous dissemination of the same parasite.

Advantages of the New Coding:

Simplification: a single code for all extraintestinal forms
Flexibility: allows narrative documentation of the specific location without fragmenting statistics
Consistency: facilitates aggregated epidemiological analyses of severe forms of amebiasis

Practical Impact:

For professionals accustomed to ICD-10, the transition requires mental adjustment: instead of searching for specific codes for liver abscess versus lung abscess, all are now 1A36.1. Detailed anatomical specification should be included in the narrative clinical documentation, but no longer in primary coding. Electronic health record systems may require updating to reflect this consolidation, and training of coding teams is essential to prevent persistent use of ICD-10 logic.

9. Frequently Asked Questions

1. How is definitive diagnosis of extraintestinal Entamoeba infection made?

Definitive diagnosis combines clinical, radiological, and laboratory criteria. Serology for E. histolytica is the most sensitive and specific test, positive in more than 90% of cases of amebic liver abscess. Imaging studies (ultrasound, computed tomography, or magnetic resonance imaging) demonstrate characteristic extraintestinal lesions. In selected situations, image-guided aspiration can provide material for analysis, although it is generally not necessary for diagnosis. The typical appearance of aspirated material (reddish-brown fluid, described as "anchovy paste") is suggestive but not pathognomonic. Molecular tests (PCR) on aspirated material increase diagnostic specificity when available.

2. Is treatment available in public health systems?

Yes, medications used in the treatment of extraintestinal amebiasis, particularly metronidazole, are widely available in public health systems globally, appearing on essential medication lists of international health organizations. Treatment consists of two phases: tissue agents (metronidazole or tinidazole) to eliminate invasive trophozoites, followed by luminal agents (paromomycin or diloxanide furoate) to eradicate intestinal cysts and prevent recurrence. Typical treatment duration ranges from 10 to 14 days, with subsequent clinical and radiological monitoring. In complicated cases, drainage procedures may be necessary, available at hospital centers with radiological or surgical intervention capacity.

3. How long does treatment last and what is the prognosis?

Pharmacological treatment of extraintestinal amebiasis typically lasts 10 to 14 days, although clinical response (defervescence, pain improvement) generally occurs within 72 hours of initiating appropriate therapy. Complete radiological resolution of abscesses is slower, potentially taking weeks to months. The prognosis is excellent when diagnosis is established early and treatment initiated promptly, with cure rates exceeding 95%. Complications such as abscess rupture, extension to adjacent structures, or cerebral involvement significantly worsen the prognosis. Factors that negatively influence outcome include delayed diagnosis, advanced age, immunosuppression, and presence of multiple abscesses.

4. Can this code be used in medical certificates and occupational documentation?

Yes, code 1A36.1 can and should be used in medical certificates when appropriate, as it represents a legitimate medical condition that frequently requires time off from work activities. The severity of extraintestinal Entamoeba infection justifies periods of absence that may range from weeks to months, depending on the location, extent of infection, and treatment response. In occupational documentation, it is important to specify not only the code but also describe resulting functional limitations (inability to perform intense physical activities, need for rest, frequent outpatient treatment). Documentation should be clear about the treatable nature of the condition and expectation of complete recovery with appropriate therapy.

5. Do patients with extraintestinal infection always have concomitant intestinal symptoms?

No. Surprisingly, many patients with amebic liver abscess do not present with diarrhea or intestinal symptoms at the time of diagnosis. Studies demonstrate that fewer than half of patients with amebic liver abscess have active diarrhea. The primary intestinal infection may have been asymptomatic or occurred weeks to months earlier, with spontaneous resolution before development of extraintestinal manifestation. This temporal dissociation explains why parasitological examination of stool is frequently negative in patients with extraintestinal disease, making serology the most reliable diagnostic test.

6. What is the difference between Entamoeba histolytica and Entamoeba dispar and how does this affect coding?

Entamoeba histolytica is the pathogenic species capable of causing tissue invasion and extraintestinal disease, while Entamoeba dispar is morphologically identical but non-invasive and non-pathogenic. This distinction is crucial for coding: only E. histolytica infections justify code 1A36.1. Differentiation between species requires specific tests (detection of species-specific antigens, PCR, or serology), as conventional microscopy does not distinguish them. Asymptomatic carriers of E. dispar do not require treatment or coding as active disease. Clinically, the presence of invasive extraintestinal manifestations practically confirms E. histolytica as the etiological agent.

7. Is hospitalization necessary for treatment of extraintestinal Entamoeba infection?

The need for hospitalization depends on the severity of clinical presentation. Uncomplicated liver abscesses in stable patients can be treated on an outpatient basis with oral antibiotics and rigorous clinical follow-up. However, hospitalization is frequently recommended for: patients with significant systemic toxicity, large abscesses (>5 cm) with rupture risk, location in the left lobe (greater risk of rupture into pericardium), extraintestinal manifestations in critical locations (brain, pericardium), need for percutaneous or surgical drainage, or patients who do not respond to initial outpatient treatment. Hospitalization allows intensive monitoring, administration of intravenous medications, and rapid intervention in case of complications.

8. Is there risk of recurrence after adequate treatment?

The risk of recurrence after complete and adequate treatment of extraintestinal amebiasis is low, generally less than 5%. Recurrences are more common when: treatment does not include a luminal agent to eradicate intestinal cysts, there is reexposure to the parasite in endemic areas with inadequate sanitary conditions, or underlying immunosuppression. To minimize recurrence, it is essential to complete both phases of treatment (tissue agent and luminal agent), implement rigorous personal hygiene measures, ensure access to potable water and safe food, and perform clinical and radiological follow-up until complete resolution of lesions is documented. Patients with risk factors for reexposure may benefit from specific education on prevention.

Conclusion:

The ICD-11 code 1A36.1 for extraintestinal Entamoeba infections represents an essential tool for accurate documentation of a serious complication of amebiasis. Appropriate coding requires clear understanding of diagnostic criteria, differentiation of intestinal forms and other etiologies of abscesses, and complete documentation of clinical, laboratory, and radiological findings. Healthcare professionals should be alert to the varied clinical presentation of these infections, maintaining high suspicion in appropriate epidemiological contexts. The transition from ICD-10 to ICD-11 simplified coding by consolidating multiple extraintestinal locations under a single code, facilitating epidemiological analyses and improving consistency of medical records globally. Early recognition and appropriate treatment result in excellent prognosis, making accurate coding not merely an administrative matter but an integral component of quality clinical care.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-04

Extraintestinal Infections by Entamoeba

Compartir